Connect your AI

Transcat TRNS FX & Other Adjustments

FX & Other Adjustments at other companies

Charles River LaboratoriesCRL

-$18.55M-160%

Segments

By segment

Distribution$0—

Other financials

Income statement

Revenue$89.3M+15.8%

Gross profit$30.5M+17.6%

Operating income$4.3M-37.6%

Net income$1.9M-56.4%

EPS (diluted)$0.20-58.3%

Balance sheet

Cash & equivalents$4.9M+226%

Total debt$133.6M+131%

Total equity$300.6M+4.8%

Total assets$480.5M+24.7%

Cash flow

Operating cash flow$6.2M-41.7%

CapEx$3.6M+33.2%

Free cash flow$2.6M-67.1%

Valuation

Market cap$858.22M+14.4%

Enterprise value$986.87M+22.3%

P/E159.6×+108×

P/S2.6×-0.1×

Profitability

Gross margin32.6%+0.5pp

Operating margin4%-2.4pp

Net margin1.6%-3.6pp

FCF margin5.9%-3.4pp

Returns & leverage

Return on equity1.8%-3.8pp

Debt / equity0.4×+0.2×

Current ratio2.3×0.0×

Where this comes from

Reported directly by Transcat in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: Transcat’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Transcat's fx & other adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Transcat's FX & other adjustments?: Transcat (TRNS) reported FX & other adjustments of $204K in Q4 2025.
How has Transcat's FX & other adjustments changed year-over-year?: Transcat's FX & other adjustments increased by 153.1% year-over-year, from -$384K to $204K.